SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 30, 16:00
639.70
13.05 (2.08%)
VOLUME 143,842
LIVE
NSE
Sep 30, 17:00
639.70
12.85 (2.05%)
VOLUME 1,425,855
Business News on Ranbaxy Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
USFDA bans two Indian plants on GMP violations

9.28 pm | 26 Sep 2014 |  Source: CNBC-TV18

The USFDA has served import alerts to Canadian drug company Apotex Research’s manufacturing facility in Bangalore and Indian firm Micro Labs manufac...

Forbes India rich list: Mukesh Ambani tops, Adani moves up

8.54 am | 25 Sep 2014 |  Source: Moneycontrol.com

Mukesh Ambani tops the list for the eighth consecutive year with a net worth of USD 23.6 billion, followed by Dilip Shanghvi of Sun Pharma. However, t...

Sun-Ranbaxy deal: CCI public scrutiny deadline ends today

6.40 pm | 24 Sep 2014 |  Source: PTI

This is also the first M&A deal where the Competition Commission of India (CCI) has ordered a public scrutiny of after forming a "prima facie opinion ...

Epirus, Ranbaxy win India approval for arthritis drug copy

8.08 am | 16 Sep 2014 |  Source: Reuters

The market for copycat biotech drugs, known as biosimilars, is becoming more lucrative as patents expire on older, high-priced antibody drugs that ran...

Pfizer, Ranbaxy win dismissal of lawsuit over Lipitor

12.41 pm | 13 Sep 2014 |  Source: Reuters

The lawsuit stems from a 2008 settlement of a patent lawsuit filed by Pfizer against Ranbaxy over Ranbaxy's plan to make generic Lipitor. Under the de...

US drug patent expiries to benefit Indian pharma industry

9.00 am | 11 Sep 2014 |  Source: PTI

Indian pharmaceutical companies have an opportunity to capitalise on the patent cliff and gain a greater share of the growing generics market....

CCI begins Sun-Ranbaxy deal's public scrutiny; seeks notes

1.02 pm | 04 Sep 2014 |  Source: PTI

The CCI said the public consultation process has been launched "in order to determine whether the combination has or is likely to have an appreciable ...

CCI expands probe into Sun Pharma-Ranbaxy deal

12.19 pm | 28 Aug 2014 |  Source: PTI

Sun Pharma and Ranbaxy, which had announced a USD 4-billion deal in April this year, were asked late last night to make public details of their propos...

Can Indian pharma sector lead the bull run from hereon?

4.01 pm | 25 Aug 2014 |  Source: Moneycontrol.com

The S&P Healthcare index is up nearly 32 percent this year, compared to 25 percent rally on the stock exchanges benchmark 30-share index Sensex. ...

ITC replaces TCS as India's most admired company

8.30 am | 25 Aug 2014 |  Source: IBNLive.com

In the latest list for the year 2014, ITC is followed by engineering and infrastructure major Larsen and Toubro (L&T), another FMCG giant Hindustan Un...

Bitter pill gets bitterer: Ranbaxy faces Rs 240-cr US fine

8.35 am | 22 Aug 2014 |  Source: Moneycontrol.com

While specific details of the fine are still awaited, CNBC-TV18 reports the fine by the US Department of Justice could be possibly over violations in ...

12
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.